Skip to main content
. Author manuscript; available in PMC: 2016 Feb 9.
Published in final edited form as: Biomaterials. 2014 Apr 8;35(21):5491–5504. doi: 10.1016/j.biomaterials.2014.03.039

Fig. 3.

Fig. 3

Surface expression of activation and maturation markers in primary BMDCs. Bar graph showing percentage and median fluorescent intensity (MFI) of CD11c+ BMDCs expressing A) CD86, B) MHCII, C) both CD6 and MHCII, D) CD80 and E) CD40 following the treatment with different formulations of CpG, IL10-siRNA and pDNA each at 1 ug/ml concentration for 48hrs; *P<0.05 and **P<0.01 when compared between the groups.